Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=51 Randomized Single-blind Treatment

Chiropractic for Hypertension in Patients

Hypertension

Bottom Line

View on ClinicalTrials.gov: NCT01020435 ↗
Enrolled (actual)
51
Serious AEs
0.0%
Results posted
Feb 2018
Primary outcome: Primary: Unadjusted and Adjusted Changes From Baseline in Systolic and Diastolic Blood Pressure at Weeks 1, 3, 6 — -1.2; -5.3; 0.8; -1.7 mmHg

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Spinal Manipulation (Other); Sham Spinal Manipulation (Other)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Palmer College of Chiropractic
Primary completion
Apr 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Unadjusted and Adjusted Changes From Baseline in Systolic and Diastolic Blood Pressure at Weeks 1, 3, 6		 -1.2; -5.3; 0.8; -1.7; -3.6; -3.3 —

Summary

The investigators propose a prospective randomized 2 arm parallel observer-blinded phase II clinical study comparing a distinct method of upper cervical chiropractic manipulation to a sham technique in 50 individuals with stage I hypertension (systolic blood pressure (SBP): 140-159 mm Hg; diastolic blood pressure (DBP):90-99 mm Hg).

Eligibility Criteria

Inclusion Criteria

  • Age > 21 and 159mm Hg (AND) Avg DBP 99mm Hg
  • Any single SBP > 160mm Hg or DBP> 100
  • BMI > 40
  • Prescription medications with increased risk for CVA
  • Current use of anti-coagulant medication/blood thinners
  • Active drug or alcohol addiction or abstinent 2.5mg/dL
  • Abnormal Liver function tests
  • Anemia with hematocrit < 30%
  • Glucose in Urine
  • Serum potassium <3.4 @ baseline
  • S/S Renal artery stenosis
  • Quebec Task Force Classification 4-9
  • Self-reported Arnold Chiari malformation
  • Spinal or paraspinal tumors
  • Dx with disorder that exhibit spinal joint hypermobility (Marfan Syndrome, Ehlers-Danlos Syndrome, Osteogenesis imperfecta)
  • Unstable endocrine disorders
  • Osteoporosis
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01020435). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search